Vikram Bhatia

Dr. Vikram Bhatia

Pediatrics & Child Health, University of Manitoba, Winnipeg, Manitoba, Canada
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
VBVikram Bhatia
Vikram Bhatia
MGMadhu Mati Goel
Madhu Mati Goel
AMAnnu Makker
Annu Makker
STShikha Tewari
Shikha Tewari
AYAlka Yadu
Alka Yadu
SGSudhir K. Goel
Sudhir K. Goel
Promoter methylation and relative gene expression of O6-methyguanine-DNA-methyltransferase (MGMT) andp16genes were examined in tissue and blood samples of patients with premalignant oral lesions (PMOLs) and oral squamous cell carcinoma (OSCC). Methylation-specific PCR and reverse transcriptase PCR were performed in 146 tissue and blood samples from controls and patients with PMOLs and OSCC. In PMOL group, significant promoter methylation ofMGMTandp16genes was observed in 59% (P=0.0010) and 57% (P=0.0016) of tissue samples, respectively, and 39% (P=0.0135) and 33% (P=0.0074) of blood samples, respectively. Promoter methylation of both genes was more frequent in patients with OSCC, that is, 76% (P=0.0001) and 82% (P=0.0001) in tissue and 57% (P=0.0002) and 70% (P=0.0001) in blood, respectively. Significant downregulation ofMGMTandp16mRNA expression was observed in both tissue and blood samples from patients with PMOLs and OSCC. Hypermethylation-induced transcriptional silencing ofMGMTandp16genes in both precancer and cancer suggests important role of these changes in progression of premalignant state to malignancy. Results support use of blood as potential surrogate to tissue samples for screening or diagnosing PMOLs and early OSCC.

31 January 2015 in Case Reports in Hepatology
Verified
Journal Article
Open access
PDF file
MPM. Premkumar
M. Premkumar
DRDevraja Rangegowda
Devraja Rangegowda
CVChitranshu Vashishtha
Chitranshu Vashishtha
VBVikram Bhatia
Vikram Bhatia
JKJelen Singh Khumuckham
Jelen Singh Khumuckham
BKBadal Kumar
Badal Kumar
Myocarditis, an inflammatory disease of heart muscle, is an important cause of dilated cardiomyopathy worldwide. Viral infection is an important cause of myocarditis. This condition presents with various symptoms, ranging from minimally symptomatic cases to fatal arrhythmia and cardiogenic shock, and may develop chronic myocarditis and dilated cardiomyopathy in some patients. We report the case of a 26-year-old patient with acute viral hepatitis E who developed symptomatic myocarditis. As far as we could search, this is probably the 3rd case report of this rare association.

18 October 2018 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
KSKiran L. Sharma
Kiran L. Sharma
VBVikram Bhatia
Vikram Bhatia
Prasoon AgarwalPrasoon Agarwal
Prasoon Agarwal
AKAshok Kumar
Ashok Kumar

1 November 2020 in Indian Journal of Medical Research
Verified
Journal Article
Open access
PDF file
BSBhawna Sirohi
Bhawna Sirohi
SSShailesh V. Shrikhande
Shailesh V. Shrikhande
VGVinay Gaikwad
Vinay Gaikwad
APAmol Patel
Amol Patel
SPShraddha Patkar
Shraddha Patkar
FGfor the Indian Council of Medical Research Guidelines Working Group
for the Indian Council of Medical Research Guidelines Working Group
This document aims to assist oncologists in making clinical decisions encountered while managing their patients with hepatocellular carcinoma (HCC), specific to Indian practice, based on consensus among experts. Most patients are staged by Barcelona Clinic Liver Cancer (BCLC) staging system which comprises patient performance status, Child-Pugh status, number and size of nodules, portal vein invasion and metastasis. Patients should receive multidisciplinary care. Surgical resection and transplant forms the mainstay of curative treatment. Ablative techniques are used for small tumours (<3 cm) in patients who are not candidates for surgical resection (Child B and C). Patients with advanced (HCC should be assessed on an individual basis to determine whether targeted therapy, interventional radiology procedures or best supportive care should be provided. In advanced HCC, immunotherapy, newer targeted therapies and modern radiation therapy have shown promising results. Patients should be offered regular surveillance after completion of curative resection or treatment of advanced disease.

21 July 2009 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
MTMasahiro Tajika
Masahiro Tajika
TNTuneya Nakamura
Tuneya Nakamura
VBVikram Bhatia
Vikram Bhatia
KKKoji Komori
Koji Komori
TKTomoyuki Kato
Tomoyuki Kato
KYKenji Yamao
Kenji Yamao

1 December 2021 in Journal of Digestive Endoscopy
Verified
Journal Article
Open access
PDF file
VBVikram Bhatia
Vikram Bhatia
VBVaishali Bhardwaj
Vaishali Bhardwaj
HTHarsh Vardhan Tevethia
Harsh Vardhan Tevethia
Endoscopic accessories are critical devices that breach sterile body sites. They have unique reprocessing difficulties compared with other medical and surgical devices because of their complex structure, narrow lumens, thermolabile construction materials, and application through a semicritical endoscopic device. In addition, there is the possibility of functional derangement of endoscopic accessories with reprocessing, and most are now marketed as single-use devices. While reprocessing of endoscopes has been the subject of numerous societal guidelines, the issue of reprocessing endoscopic accessories and ancillary detachable devices used with the endoscope is seldom addressed. We summarize the existing data on the cleaning and reprocessing of endoscopic accessories.